Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...

While conducting the CLEAR SYNERGY (OASIS 9) trial, lead author Sanjit Jolly, MD continued to treat some of his patients post–myocardial infarction (MI), including his late father, with colchicine.

Patients with gout who are starting urate-lowering therapy, which can trigger a flare, have a lower risk for cardiovascular events when also given colchicine for flare prevention. "Colchicine…, an ...

Gloperba ® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Pericarditis is an inflammation of the ...

Study finds that fewer patients with gout received useful colchicine drug after FDA actions led to 50x increase in price. Well intentioned, but costly and potentially problematic. That's how ...